The state board that oversees Iowa’s medical cannabis industry has declined to add any new conditions to the list of approved uses.
The Medical Cannabidiol Board today denied petitions to approve anxiety and schizophrenia. A decision whether to approve post-traumatic stress disorder was delayed until November.
MedPharm, the company that manufactures medical marijuana in Iowa is introducing a line of medical cannabis vapor products that will soon be available. MedPharm has a dispensary in Sioux City.